By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ariad Pharmaceuticals, Inc. 

26 Landsdowne Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-494-0400 Fax: 617-494-8144


SEARCH JOBS

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).


Key Statistics


Email:
Ownership: Public

Web Site: Ariad Pharmaceuticals, Inc.
Employees:
Symbol: ARIA
 









Company News
MA's Ariad Pharmaceuticals, Inc. (ARIA) Inks $75 Million+ Commercialization Deal In Asia 12/23/2014 6:34:00 AM
Ariad Pharmaceuticals, Inc. (ARIA) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 12/22/2014 9:52:07 AM
Ariad Pharmaceuticals, Inc. (ARIA) Announces Follow-Up Data From Phase 1 And PACE Trials Of Ponatinib In Patients With T315I Mutation In Chronic Myeloid Leukemia 12/9/2014 1:17:29 PM
Ariad Pharmaceuticals, Inc. (ARIA) Announces Long-Term Safety And Efficacy Data Of Ponatinib In Chronic-Phase Chronic Myeloid Leukemia From Phase 1 Clinical Trial 12/9/2014 1:12:43 PM
Ariad Pharmaceuticals, Inc. (ARIA) Announces Long-Term Safety And Efficacy Data Of Ponatinib From Phase 2 Pace Clinical Trial 12/8/2014 12:01:22 PM
Ariad Pharmaceuticals, Inc. (ARIA) And Specialised Therapeutics Australia Announce Approval Of Iclusig (Ponatinib) In Australia 11/24/2014 9:38:04 AM
Ariad Pharmaceuticals, Inc. (ARIA) Announces Iclusig Data Presentations At Annual American Society of Hematology Meeting 11/6/2014 11:39:02 AM
Ariad Pharmaceuticals, Inc. (ARIA) Reports Third Quarter 2014 Financial Results And Development Progress 11/5/2014 10:07:28 AM
Ariad Pharmaceuticals, Inc. (ARIA) To Present At The Stifel 2014 Healthcare Conference 11/4/2014 10:01:44 AM
Ariad Pharmaceuticals, Inc. (ARIA) Announces Adoption of Final Opinion For Iclusig By Committee For Medicinal Products For Human Use In Europe 10/24/2014 9:42:07 AM
12345678910...
//-->